Disclosure Of Non-Current Assets Held For Sale And Discontinued Operations [Text Block]

BerGenBio - Filing #2615544

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Disclosure of non-current assets held for sale and discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [text block]
Disclosure of analysis of single amount of discontinued operations [abstract]
Disclosure of analysis of single amount of discontinued operations [line items]
Profit (loss) before tax
309,364,000 NOK
257,029,000 NOK
Revenue
774,000 NOK
601,000 NOK
Cash flows from continuing and discontinued operations [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operating activities
303,340,000 NOK
234,290,000 NOK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) investing activities
3,130,000 NOK
3,548,000 NOK
Cash flows from (used in) financing activities [abstract]
Cash flows from (used in) financing activities
15,995,000 NOK
699,507,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.